THERMO FISHER SCIENTIFIC

(TMO)
  Report
Delayed Nyse  -  04:00 2022-08-10 pm EDT
592.35 USD   +1.98%
04:34pTHERMO FISHER SCIENTIFIC : Statement of Changes in Beneficial Ownership - Form 4
PU
08/08Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit
CI
08/05THERMO FISHER SCIENTIFIC INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific Inc Announces FDA Clears Thermo Scientific EliA RNA Pol III and EliA Rib-P Tests for Use in U.S

06/09/2022 | 08:00am EDT

Thermo Fisher Scientific Inc. announced Thermo Scientific EliA RNA Pol III and EliA Rib-P tests have been cleared by the U.S. Food & Drug Administration (FDA) for aiding in the diagnosis of Systemic Sclerosis (SSc; scleroderma) and Systemic Lupus Erythematosus (SLE). With these new tests, the EliA portfolio provides a more robust clinical offering through a comprehensive menu of automated connective tissue disease tests. RNA Polymerase III is a criteria marker for SSc with both diagnostic and prognostic value.[1, 2] Additionally, in patients who are positive for RNA Polymerase III, up to 70% may have no other SSc associated antibodies present.[2] The EliA RNA Pol III test completes a criteria based EliA SSc panel and is the first fully automated RNA Polymerase test available in the U.S. A subset of SLE patients present with monospecific Ribosomal P antibodies.[3] Detection of these autoantibodies via indirect immunofluorescence has been shown to be an unreliable method, which if used solely, could result in delayed diagnosis and treatment.[4] The EliA Rib-P test is designed with optimal sensitivity and specificity and can be used to support the diagnosis of SLE, particularly in ANA negative patients.


© S&P Capital IQ 2022
All news about THERMO FISHER SCIENTIFIC
04:34pTHERMO FISHER SCIENTIFIC : Statement of Changes in Beneficial Ownership - Form 4
PU
08/08Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit
CI
08/05THERMO FISHER SCIENTIFIC INC. Management's Discussion and Analysis of Financial Condit..
AQ
08/04Thermo Fisher Scientific Introduces Highly Sensitive Research Assays for Measurable Res..
CI
08/04THERMO FISHER SCIENTIFIC : Expands Cell Culture Media Manufacturing Site in Grand Island N..
PU
08/03INSIDER SELL : Thermo Fisher Scientific
MT
08/03Thermo Fisher Scientific and Structura Biotechnology Collaborate to Offer a Solution fo..
BU
08/03Thermo Fisher Scientific Inc. and Structura Biotechnology Inc. Collaborate to Offer Sol..
CI
08/01Thermo Fisher Scientific Inc. Unveils Thermo Scientific Arctis Cryo-Plasma Focused Ion ..
CI
08/01Barclays Adjusts Price Target on Thermo Fisher Scientific to $685 From $630, Reiterates..
MT
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2022 43 124 M - -
Net income 2022 6 884 M - -
Net Debt 2022 24 684 M - -
P/E ratio 2022 34,1x
Yield 2022 0,20%
Capitalization 232 B 232 B -
EV / Sales 2022 5,95x
EV / Sales 2023 5,72x
Nbr of Employees 130 000
Free-Float 88,7%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 592,35 $
Average target price 661,45 $
Spread / Average Target 11,7%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
THERMO FISHER SCIENTIFIC-11.22%227 578
DANAHER CORPORATION-13.30%207 497
INTUITIVE SURGICAL, INC.-35.19%83 164
EDWARDS LIFESCIENCES CORPORATION-21.70%62 887
BOSTON SCIENTIFIC CORPORATION-3.41%58 739
SIEMENS HEALTHINEERS AG-22.79%58 199